Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -120,552 | -82,404 | -58,868 | -29,289 | -96,968 |
| Depreciation Amortization | 5,518 | 3,548 | 2,398 | 1,199 | 5,069 |
| Income taxes - deferred | 5 | N/A | N/A | N/A | N/A |
| Accounts receivable | 2,023 | 2,300 | 2,928 | -24 | 2,435 |
| Other Working Capital | -3,543 | -15,180 | -10,456 | -9,022 | 4,709 |
| Other Operating Activity | 18,698 | 7,624 | 7,619 | 4,681 | 11,204 |
| Operating Cash Flow | $-97,850 | $-84,113 | $-56,379 | $-32,454 | $-73,550 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -100,950 | -18,606 | -27,010 | -48,678 | -88,155 |
| PPE Investments | -988 | -874 | -740 | -659 | -2,085 |
| Sale Of Investment | 92,893 | N/A | N/A | N/A | 132,660 |
| Investing Cash Flow | $-9,045 | $-19,480 | $-27,750 | $-49,337 | $42,420 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 97,444 | 93,426 | 75,659 | 75,659 | N/A |
| Debt Repayment | -3,315 | -3,315 | N/A | N/A | N/A |
| Common Stock Issued | 9,202 | 3,517 | 2,389 | 920 | 31,649 |
| Other Financing Activity | 2,067 | 2,124 | 2,124 | 2,298 | -612 |
| Financing Cash Flow | $105,398 | $95,752 | $80,171 | $78,877 | $31,037 |
| Beginning Cash Position | 23,694 | 23,694 | 23,694 | 23,694 | 23,787 |
| End Cash Position | 22,196 | 15,853 | 19,736 | 20,779 | 23,694 |
| Net Cash Flow | $-1,498 | $-7,840 | $-3,958 | $-2,915 | $-93 |
| Free Cash Flow | |||||
| Operating Cash Flow | -97,850 | -84,113 | -56,379 | -32,454 | -73,550 |
| Capital Expenditure | -988 | -874 | -740 | -659 | -2,085 |
| Free Cash Flow | -98,838 | -84,986 | -57,119 | -33,113 | -75,635 |